InstaRX review
InstaRX is a multi-product compounded-medication telehealth platform offering GLP-1 injections (semaglutide and tirzepatide) alongside anti-aging peptides (NAD+, Sermorelin, B12/MIC) and sexual-health…
- Scores never bought
- 537 providers tracked
- Every factor auditable
- Updated August 2026
Semaglutide here is $252/mo — $53 above our category median of $199.
- Semaglutide
- $252/mo
- Tirzepatide
- $353/mo
- Coverage
- All 50 states
- Brand-name
- Compounded only
- Oral option
- Injectable only
- Verification
- Not independently listed
Best for: People who want compounded GLP-1 plus peptides and sexual health on one account.
MatchScript's take: Our #313 pick of 537 — confirmed nationwide access.
The factor breakdown
InstaRX on the six Match Score factors — the same sub-scores the quiz reweights to your priorities. See the methodology.
Semaglutide from $252/mo puts Budget Fit at a below-par 43 — above the budget tiers.
Confirmed all-50-state access means it can usually prescribe within days, for a strong 92 on Speed to Start.
InstaRX sticks to compounded injectables, for a below-par 66 on Formulary Match.
Support lands at a below-par 70 — lighter, meds-first support.
Flexibility scores a below-par 55 — fewer levers to flex your plan.
Thinner public disclosure than the top of the ranking keeps Transparency at a below-par 46.
Pricing in context
How InstaRX's monthly price sits against the category median and the cheapest provider we track.
What we like
- Available in all 50 states plus DC
- Manage GLP-1, anti-aging peptides, and sexual-health medications on one account
- Offers both compounded semaglutide and compounded tirzepatide
- Independent provider group (Dr Telx) named in the Terms of Service
The caveats
- No per-dose or monthly pricing published — only a "$199 to get started" hook; you can't compare costs before intake
- No LegitScript, HIPAA, or NABP accreditation shown on public pages
- Compounding pharmacy not named — only "U.S. pharmacies"
- Terms of Service reads like generic boilerplate, including copy-paste language about women's health issues — suggests low template hygiene
- Delaware governing law for disputes despite a California corporate address
Who it's for — and who should skip it
InstaRX is for people who want compounded GLP-1 plus peptides and sexual health on one account.
Skip it if that doesn't sound like you. A closer fit may be MEDGm (Match Score 60) — or take the quiz to see where InstaRX lands for your priorities.
How it compares to CoreAge Rx & the closest scorer
InstaRX against our #1 overall pick and the provider that scores closest to it. Green marks the row leader.
| How it compares | InstaRXthis provider | CoreAge Rxour #1 | LevelsRxclosest scorer |
|---|---|---|---|
| Sema price | $252/mo | $99/mo at every dose | $253/mo |
| Coverage | All 50 states | All 50 states | Coverage not published |
| Formulary | Injectable | Injectable | Injectable + oral |
| Match Score | 61 · C | 91 · A− | 61 · C |
InstaRX, answered
Is InstaRX legit?
InstaRX is a real, operating GLP-1 telehealth program. LegitScript certification is the third-party check worth asking for — look for the seal on their site and confirm your prescriber is US-licensed at intake. Like most programs here it dispenses compounded GLP-1s, which are made by a licensed pharmacy but aren't FDA-approved.
How much does InstaRX cost?
InstaRX lists compounded semaglutide from $252/mo and tirzepatide from $353/mo — above our category median of $199/mo. These are the provider's public figures at our last review (August 2026); confirm on their site, since some teaser tiers step up after month one.
Does InstaRX ship to my state?
Yes — InstaRX reports availability in all 50 states, so most people can start within days.
InstaRX vs MEDGm — which should I pick?
They score within a few points of each other: InstaRX at 61/100 and MEDGm at 60/100, so neither wins on the headline number. InstaRX is the better fit for people who want compounded GLP-1 plus peptides and sexual health on one account. MEDGm suits people who want four named pharmacies and a fifty-state footprint, and who will click the coupon off before deciding what the program costs. Run the quiz and the weighting shifts to whichever of those matters more to you.
Pricing & state data last verified August 2026 from InstaRX's public site and our master provider matrix. The Match Score and its sub-scores are our editorial judgment per the methodology. Commercial facts only — prices change, so confirm on InstaRX's site. Not medical advice; see our disclosure.
Semaglutide here is $252/mo — $53 above our category median of $199. Tirzepatide is $353/mo. It scores highest on how quickly you can start. Best suited to people who want compounded GLP-1 plus peptides and sexual health on one account. If that is not you, MEDGm is the closest thing to it here.
Compare with other providers
Our next-best picks in default ranking order, then the 24 programs that sit nearest InstaRX here.
- #1Match91/ 100CoreAge RxThe best all-around match: nationwide access, both molecules at one flat, no-surprise price, and an easy exit.91/100
- #2Match84/ 100Strut HealthThe only program here carrying both LegitScript and ACHC accreditation, with an oral lozenge route on both molecules at the cheapest entry in this ranking.84/100
- #3Match83/ 100EdenA polished, high-disclosure compounded program with strong nationwide coverage and hands-on support.83/100
- #4Match85/ 100RoA heavyweight telehealth brand with brand-name access and a polished experience — but opaque compounded pricing.85/100
- #5Match85/ 100No BS RXThe highest Transparency score here, and it is not close: twenty-four prices on one public page and four dispensing pharmacies named with street addresses.85/100
Compare 24 nearby providersHide them
| Provider | Tirzepatide price | Coverage | Alternatives | Go | ||
|---|---|---|---|---|---|---|
| Tuyo Health#314 FDA issued Tuyo Health, Inc. dba Tuyo Health a warning letter in September 2025. See FDA's warning-letter database. | 61 | $155/mo | $349/mo | Coverage not published | Alternatives | Visit |
| MyStart Health#315 FDA issued Matthew Stern, CEO MyStart Health LLC. a warning letter in September 2025. See FDA's warning-letter database. | 61 | $303/mo | $303/mo | Coverage not published | Alternatives | Visit |
| Freya Meds#316 | 61 | $301/mo | $396/mo | Coverage not published | Alternatives | Visit |
| The Aesthetic Concierge#317 | 61 | $417/mo | Not disclosed | 13 states | Alternatives | Visit |
| BeyondMD#318 | 61 | $139/mo (starting dose, compounded) | $209/mo (starting dose, compounded) | Coverage not published | Alternatives | Visit |
| FuturHealth#319 | 61 | $199/mo (compounded) | Not disclosed | Coverage not published | Alternatives | Visit |
| Human+#320 | 61 | Not disclosed | Not disclosed | All 50 states | Alternatives | Visit |
| iThriveMD#321 | 61 | $325/mo | $434/mo | Coverage not published | Alternatives | Visit |
| Noom Med#322 | 61 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Transparent Meds#323 | 61 | $229/mo (promotional rate, compounded) | $349/mo (compounded) | Coverage not published | Alternatives | Visit |
| WeightWatchers Clinic#324 | 61 | Not disclosed | Not disclosed | All 50 states | Alternatives | Visit |
| Carocare Wellness#325 | 61 | $152/mo | $203/mo | 1 state | Alternatives | Visit |
| Dr. Arevitalize#326 | 61 | $269/mo | $359/mo (compounded) | Coverage not published | Alternatives | Visit |
| Ryze Rx#327 | 61 | $199/mo (starting dose, 3 month plan, compounded) | $166/mo | Coverage not published | Alternatives | Visit |
| Next Vial#328 | 61 | $199/mo | Not disclosed | 49 states | Alternatives | Visit |
| Novi#329 | 61 | $149/mo | $405/mo | Coverage not published | Alternatives | Visit |
| Rewinding RX#330 | 61 | $141/mo | $192/mo | All 50 states | Alternatives | Visit |
| HealthHub#331 | 61 | $100/mo | $202/mo | Coverage not published | Alternatives | Visit |
| Solaya MD#332 | 61 | Not disclosed | Not disclosed | All 50 states | Alternatives | Visit |
| Lttl#333 | 58 | $216/mo | $303/mo | Coverage not published | Alternatives | Visit |
| Fifty 410#334 FDA issued Aspen Aesthetics dba Fifty 410 a warning letter in February 2026. See FDA's warning-letter database. | 60 | $199/mo | $133/mo (starting dose, compounded) | Coverage not published | Alternatives | Visit |
| Ivim Health#335 | 60 | $268/mo | $355/mo | Coverage not published | Alternatives | Visit |
| TeleHealth Med#336 | 60 | $263/mo | Not disclosed | Coverage not published | Alternatives | Visit |
| June Health#337 | 60 | $283/mo | $202/mo | Coverage not published | Alternatives | Visit |
InstaRX is ranked on our best semaglutide providers, best tirzepatide providers and best GLP-1 programs boards, scored on the same six factors as every other provider there.